CD8A and acute lymphoblastic leukemia: Furthermore, enhanced differentiation of ZEB2Tg ETP-ALL was detected upon GSK-LSD1i with Ruxolitinib or ABT-199 in the blood (higher levels of DN4 T cells) and in the thymus (enhanced SP CD4+CD8− levels).